This is an old revision of this page, as edited by Louisajb (talk | contribs) at 12:21, 9 December 2011 (added structure). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 12:21, 9 December 2011 by Louisajb (talk | contribs) (added structure)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Acrisorcin" – news · newspapers · books · scholar · JSTOR (May 2008) (Learn how and when to remove this message) |
Combination of | |
---|---|
4-Hexylresorcinol | Antiseptic |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.028.536 |
Chemical and physical data | |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Acrisorcin is a topical anti-infective typically used as a fungicide. It is a combination of the active ingredients 9-aminoacridine and 4-hexylresorcinol.
History
Acrisorcin was marketed as a cream under the trade name Akrinol, which has since been discontinued. It was developed at Indiana State University in 1961.
Indications
Acrisorcin was used to combat pityriasis versicolor.
References
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |